Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseasesCong‐Fei Xu, Jun Wang, Hongjun Li et al.|Nature Communications|2018Cited by 193
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseasesQian Huang, Yi Huang, Yi Ru et al.|Science Advances|2024Cited by 153
Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell interventionMin Li, Jun Wang, Ya-Nan Fan et al.|Nano Research|2018Cited by 41
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating ironYi Ru, Yi Huang, Ying‐Li Luo et al.|International Immunopharmacology|2024Cited by 28
Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapyYing‐Li Luo, Yinchu Ma|Acta Pharmaceutica Sinica B|2024Cited by 17